Cirkulerende tumorceller kan muligvis benyttes som prognostisk og prædiktiv markør ved ventrikelcancer

Research output: Contribution to journalJournal articleResearchpeer-review

Cecilie Okholm, Morten Thorsteinsson, Michael Patrick Achiam

Despite chemotherapy and intended curative surgery, approximately 50% of patients with gastric cancer develop recurrence and eventually die of metastatic disease. The detection of circulating tumour cells (CTC) in peripheral blood is a promising prognostic and predictive marker. The most typically applied approaches to the detection of CTC are RT-PCR and immunological assays. Measurement of CTC in gastric cancer seems useful for predicting prognosis and monitoring response of chemotherapy. There is still no gold standard for CTC-detection in gastric cancer patients and larger studies are needed.

Original languageDanish
Article numberV01130083
JournalUgeskrift for Laeger
Issue number16
Pages (from-to)1490-1493
Number of pages4
Publication statusPublished - 4 Aug 2014

ID: 138807068